GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Additional Paid-In Capital

HLB Therapeutics Co (XKRX:115450) Additional Paid-In Capital : ₩0 Mil(As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Additional Paid-In Capital?


HLB Therapeutics Co's quarterly additional paid-in capital increased from Sep. 2023 (₩123,194 Mil) to Dec. 2023 (₩125,176 Mil) but then stayed the same from Dec. 2023 (₩125,176 Mil) to Mar. 2024 (₩0 Mil).

HLB Therapeutics Co's annual additional paid-in capital declined from Dec. 2021 (₩190,850 Mil) to Dec. 2022 (₩97,290 Mil) but then increased from Dec. 2022 (₩97,290 Mil) to Dec. 2023 (₩125,176 Mil).


HLB Therapeutics Co Additional Paid-In Capital Historical Data

The historical data trend for HLB Therapeutics Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Additional Paid-In Capital Chart

HLB Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106,293.06 145,207.48 190,849.96 97,290.23 125,175.79

HLB Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110,765.10 123,429.46 123,194.03 125,175.79 -

HLB Therapeutics Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

HLB Therapeutics Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines